Liposome-based drug co-delivery systems in cancer cells

被引：239
作者：
Vahed, Sepideh Zununi [1 ]
Salehi, Roya [1 ,2 ]
Davaran, Soodabeh [1 ,2 ]
Sharifi, Simin [2 ,3 ]
机构：
[1] Tabriz Univ Med Sci, Chron Kidney Dis Res Ctr, Tabriz, Iran
[2] Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran
[3] Tabriz Univ Med Sci, Fac Pharm, Dept Pharmaceut Biotechnol, Tabriz, Iran
来源：
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS | 2017年 / 71卷
关键词：
Liposome; Co-delivery; Combination therapy; Chemotherapy; Cancer treatment; VASCULOGENIC MIMICRY CHANNELS; LARGE UNILAMELLAR VESICLES; SOLID LIPID NANOPARTICLES; EFFECTS IN-VITRO; BREAST-CANCER; ANTICANCER DRUG; VITAMIN-C; TRANSFERRIN RECEPTOR; MULTIDRUG-RESISTANCE; TARGETED LIPOSOMES;
D O I：
10.1016/j.msec.2016.11.073
中图分类号：
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号：
0805 ; 080501 ; 080502 ;
摘要：
Combination therapy and nanotechnology offer a promising therapeutic method in cancer treatment. By improving drug's pharmacoldnetics, nanoparticulate systems increase the drug's therapeutic effects while decreasing its adverse side effects related to high dosage. Liposomes are extensively used as drug delivery systems and several liposomal nanomedicines have been approved for clinical applications. In this regard, liposome-based combination chemotherapy (LCC) opens a novel avenue in drug delivery research and has increasingly become a significant approach in clinical cancer treatment This review paper focuses on LCC strategies including co-delivery of: two chemotherapeutic drugs, chemotherapeutic agent with anti-cancer metals, and chemotherapeutic agent with gene agents and ligand-targeted liposome for co-delivery of chemotherapeutic agents. Definitely, the multidisciplinary method may help improve the efficacy of cancer therapy. An extensive literature review was performed mainly using PubMed. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码：1327 / 1341
页数：15
相关论文
共 237 条
[1]   Formation of transition metall-doxorubicin complexes inside liposomes [J].
Abraham, SA ;
Edwards, K ;
Karlsson, G ;
MacIntosh, S ;
Mayer, LD ;
McKenzie, C ;
Bally, MB .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2002, 1565 (01) :41-54
[2]   Peptide-Targeted Liposomes for Selective Drug Delivery: Advantages and Problematic Issues [J].
Accardo, Antonella ;
Morelli, Giancarlo .
BIOPOLYMERS, 2015, 104 (05) :462-479
[3]   6-mercaptopurine and daunorubicin double drug liposomes - Preparation, drug-drug interaction and characterization [J].
Agrawal, V ;
Paul, MK ;
Mukhopadhyay, AK .
JOURNAL OF LIPOSOME RESEARCH, 2005, 15 (3-4) :141-155
[4]  
Ajith Thekkuttuparambil Ananthanarayanan, 2015, J Exp Ther Oncol, V11, P33
[5]   Liposome: classification, preparation, and applications [J].
Akbarzadeh, Abolfazl ;
Rezaei-Sadabady, Rogaie ;
Davaran, Soodabeh ;
Joo, Sang Woo ;
Zarghami, Nosratollah ;
Hanifehpour, Younes ;
Samiei, Mohammad ;
Kouhi, Mohammad ;
Nejati-Koshki, Kazem .
NANOSCALE RESEARCH LETTERS, 2013, 8
[6]   Monoclonal antibody-targeted, temperature-sensitive liposomes: In vivo tumor chemotherapeutics in combination with mild hyperthermia [J].
Al-Ahmady, Zahraa S. ;
Chaloin, Olivier ;
Kostarelos, Kostas .
JOURNAL OF CONTROLLED RELEASE, 2014, 196 :332-343
[7]   Nano-Polypharmacy to Treat Tumors: Coencapsulation of Drug Combinations Using Nanoparticle Technology [J].
Alexis, Frank .
MOLECULAR THERAPY, 2014, 22 (07) :1239-1240
[8]   Ligand-targeted therapeutics in anticancer therapy [J].
Allen, TM .
NATURE REVIEWS CANCER, 2002, 2 (10) :750-763
[9]   Combinatorial nanomedicines for colon cancer therapy [J].
Anitha, A. ;
Maya, S. ;
Sivaram, Amal J. ;
Mony, U. ;
Jayakumar, R. .
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY, 2016, 8 (01) :151-159
[10]   The state-of-play and future of platinum drugs [J].
Apps, Michael G. ;
Choi, Eugene H. Y. ;
Wheate, Nial J. .
ENDOCRINE-RELATED CANCER, 2015, 22 (04) :R219-R233
12345678910